Adenomyosis Patients With Infertility & Immunological Factors

Status Recruiting

Clinical Trial Summary

Infertile patients with adenomyosis who met the inclusion and exclusion criteria, after signing the informed consent form, the researchers recorded the clinical information of the patients and initiated the in vitro fertilization-embryo transfer (IVF-ET) procedure. Peripheral blood was collected on the day of embryo transfer. And if the pregnancy test was positive at 14 days after embryo transfer, peripheral blood was collected at 21 days after the transfer and every 2 weeks thereafter until 12 weeks of gestation. By analyzing the changes of immune cells and molecules in the peripheral blood of the patients, role of immune factors in infertility combined with adenomyosis was further explored.

Clinical Trial Description

Adenomyosis is a common gynecological disease in women of reproductive age which is characterized by endometrial glands and stroma in the normal myometrium, accompanied by hypertrophy of the surrounding myometrial smooth muscle cells.The results of several studies showed that clinical pregnancy rate and live birth rate of in vitro fertilization-embryo transfer decreased in infertile patients with adenomyosis. This study intends to explore the immune-related mechanisms in infertile patients with uterine adenomyosis, with a view to finding effective clinical intervention targets for adenomyosis associated infertility, and providing new clues for the prevention and treatment of adenomyosis associated infertility. Peripheral blood was collected on the day of embryo transfer. And if the pregnancy test was positive at 14 days after embryo transfer, peripheral blood was collected at 21 days after the transfer and every 2 weeks thereafter until 12 weeks of gestation. The basic characteristics of the participants, such as age, body mass index, infertility type, infertility duration, gravida, parity times, basal follicle-stimulating hormone (FSH), anti-Müllerian hormone, uterine volume before IVF cycle, controlled ovulation hyperstimulation (COH) protocol, endometrial thickness, number of embryos transferred, transferred embryo type (cleavage embryo/blastocyst) were evaluated. Pregnancy outcomes of all patients were followed up. By analyzing the changes of immune cells and molecules in the peripheral blood of the patients, role of immune factors in infertility combined with adenomyosis was further explored. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06123975
Study type	Observational
Source	Peking University Third Hospital
Contact	Wen Zhang
Phone	15510659339
Email	chaodongxiehe@163.com
Status	Recruiting
Phase
Start date	March 1, 2024
Completion date	October 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04665414` - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Recruiting	`NCT04209127` - Comparing Efficacy of Microwave vs Embolization Treatment for Adenomyosis	N/A
Completed	`NCT05751876` - Dienogest in Perimenopausal Women With Adenomyosis
Recruiting	`NCT01048931` - Single-port Access Laparoscopic-assisted Vaginal Hysterectomy	Phase 3
Active, not recruiting	`NCT06223464` - Evaluation of the Relationship Between Adenomyosis and Elastographic Properties of the Cervix
Completed	`NCT05419414` - The Use of Shear Wave Elastography, Transvaginal Ultrasound and Pelvic MRI in the Diagnosis of Adenomyosis	N/A
Recruiting	`NCT04126824` - Effect of Addition of Steroids on Duration of Analgesia	Early Phase 1
Recruiting	`NCT05152667` - Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin
Not yet recruiting	`NCT03654144` - Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis	Phase 4
Completed	`NCT01992718` - What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography	Early Phase 1
Completed	`NCT02192606` - Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?	N/A
Recruiting	`NCT02495311` - The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
Recruiting	`NCT03742843` - A Multi-omics Study of Adenomyosis
Recruiting	`NCT04481321` - Clinical and Molecular Study of Endometriosis and Adenomyosis
Recruiting	`NCT04894292` - The Effect of Adenomoyosis on Pregnancy Outcomes
Completed	`NCT03520439` - Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis	Phase 2/Phase 3
Recruiting	`NCT05937490` - Adenomyosis and ART	Phase 4
Recruiting	`NCT06373822` - New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs
Completed	`NCT01821001` - Vaginal Bromocriptine for Treatment of Adenomyosis	Phase 1
Recruiting	`NCT04295109` - Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Adenomyosis Patients With Infertility and Immunological Factors

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms